Advanced search
Publication Cover
International Journal of Radiation Biology Volume 60, 1991 - Issue 1-2
Submit an article Journal homepage
4
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Effects of Two Tumour Blood Flow Modifiers, Hydralazine and Flavone Acetic Acid, on KHT Tumours and Normal Tissues in Mice

D.J. Honess MRC Unit, MRC Centre, Hills Road, Cambridge, CB2 2QH, UK
&
N.M. Bleehen University Department of Clinical Oncology and Radiotherapeutics, MRC Centre, Hills Road, Cambridge, CB2 2QH, UK
Pages 249-253 | Published online: 03 Jul 2009

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

A. SHAKIL. (1999) Reduction of tumour blood flow with KB-R8498 potentiates the response of tumours to hyperthermia. International Journal of Hyperthermia 15:1, pages 1-6.
Read now
RM Phillips. (1998) Prospects for bioreductive drug development. Expert Opinion on Investigational Drugs 7:6, pages 905-928.
Read now

Articles from other publishers (8)

L-M Ching, Z Cao, C Kieda, S Zwain, M B Jameson & B C Baguley. (2002) Induction of endothelial cell apoptosis by the antivascular agent 5,6-dimethylxanthenone-4-acetic acid. British Journal of Cancer 86:12, pages 1937-1942.
Crossref
Bruce M Fenton. (2001) Influence of hydralazine administration on oxygenation in spontaneous and transplanted tumor models. International Journal of Radiation Oncology*Biology*Physics 49:3, pages 799-808.
Crossref
Chang W. Song, Heonjoo Park & Robert J. Griffin. 2001. Thermotherapy for Neoplasia, Inflammation, and Pain. Thermotherapy for Neoplasia, Inflammation, and Pain 394 407 .
Jane C. M. Bremner. (1993) Assessing the bioreductive effectiveness of the nitroimidazole RSU1069 and its prodrug RB6145: with particular reference toin vivo methods of evaluation. Cancer and Metastasis Reviews 12:2, pages 177-193.
Crossref
Michael C. Bibby, N. Ruth Sleigh, Paul M. Loadman & John A. Double. (1993) Potentiation of EO9 anti-tumour activity by hydralazine. European Journal of Cancer 29:7, pages 1033-1035.
Crossref
Mark W. Dewhirst, David Madwed, Robert E. Meyer, Edgardo T. Ong, Bruce Klitzman, Gary L. Rosner & Richard Dodge. (2007) Reduction in tumor blood flow in skin flap tumor after hydralazine is not due to a vascular steal phenomenon. Radiation Oncology Investigations 1:5, pages 270-278.
Crossref
Charles A. Belfi, Lai-Lei Ting, Samuel J. Hassenbusch, Melvin Tefft & Frank Q.H. Ngo. (1992) Determination of changes in tumor blood perfusion after hydralazine treatment by dynamic paramagnetic-enhanced magnetic resonance imaging. International Journal of Radiation Oncology*Biology*Physics 22:3, pages 477-482.
Crossref
D.J. Honess & N.M. Bleehen. (1992) Comparative effects of hydralazine on perfusion of kht tumor, kidney and liver and on renal function in mice. International Journal of Radiation Oncology*Biology*Physics 22:5, pages 953-961.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.